We call upon Parliament to review and reform the EU Novel Foods Regulation as it applies to traditional adaptogenic mushrooms, including turkey tail and cordyceps, which have been safely consumed across Asia for centuries.

The current regulation uses an arbitrary 1997 cutoff date that effectively bans mushroom products with extensive historical use outside Europe, while ignoring hundreds of years of documented safety evidence from billions of consumers worldwide.

This creates an unjust barrier that restricts your freedom to access natural health products used safely in traditional medicine systems, forces small businesses out of the market, and privileges European dietary history over equally valid global food traditions.

By signing this petition, you are standing up for consumer choice, cultural inclusivity in food policy, and evidence-based regulation that recognizes traditional knowledge.

You are supporting small businesses and practitioners who offer these time-tested natural products, and you are demanding that safety assessments consider real-world historical evidence rather than dismissing centuries of safe use simply because it occurred outside European borders.

Your signature helps ensure that regulatory frameworks protect consumers without creating discriminatory barriers against traditional foods from non-European cultures.

This is about fairness, access to natural health options, and ensuring our laws reflect scientific reality rather than arbitrary geographical boundaries.

Your Right to Natural Wellness is Under Threat!

This regulation directly infringes upon your fundamental freedom to make informed choices about your own health and wellness. As a sovereign individual, you should have the right to access natural substances that have been used safely for centuries to support immune function, energy levels, and overall vitality.

These are not experimental drugs or untested chemicals—they are traditional foods that have nourished and healed countless generations. By restricting your access to these mushrooms, the current law removes your ability to choose natural, holistic approaches to self-care and forces you into a narrower range of health options dictated by bureaucratic gatekeeping rather than historical evidence and personal autonomy.

The wellness journey is deeply personal. Many people are seeking alternatives to pharmaceutical interventions, looking to prevent illness rather than simply treat symptoms, and choosing to work with their body's natural healing capabilities.

Traditional adaptogenic mushrooms have been central to these approaches in Eastern medicine for millennia. Denying EU citizens access to these time-tested remedies while they remain freely available throughout Asia, North America, and other regions represents a paternalistic overreach that treats adults as incapable of making informed decisions about their own bodies and health.

The Glaring Contradiction in Our Food Standards

What makes this regulatory stance particularly egregious is the stunning hypocrisy in what the EU does permit for consumption. Consider the contradictions:

Alcohol

Alcohol is freely sold across the EU despite being a known carcinogen linked to multiple cancers, liver disease, and approximately 290,000 deaths annually in Europe alone.

Unlike mushrooms with centuries of safe use, alcohol has clear and documented harmful effects, yet faces minimal regulatory restriction.

Tobacco

Tobacco products remain legal despite causing over 700,000 deaths per year in the EU and having no nutritional or health benefits whatsoever.

These products are proven to be addictive and deadly, yet they are readily available while a mushroom used safely in tea form for centuries is classified as too dangerous without expensive authorization.

Ultra-processed foods

Ultra-processed foods containing artificial additives, excessive sugars, trans fats, and chemical preservatives are sold without the extensive authorization required for traditional mushrooms.

These modern industrial food products, with mere decades of existence, are linked to obesity, diabetes, cardiovascular disease, and numerous other health conditions, yet they flood supermarket shelves unimpeded.

Energy Drinks

Energy drinks containing high levels of caffeine, artificial stimulants, and synthetic compounds are marketed to young people despite documented cases of adverse effects, hospitalizations, and even deaths. These products have virtually no history of traditional use, yet face far fewer barriers to market than mushrooms consumed safely for hundreds of years.

Artificial sweeteners

Artificial sweeteners and food colourings, some of which have been linked to potential health concerns in various studies, are permitted in countless products. These are genuinely novel chemical substances with limited long-term safety data compared to traditional mushrooms.

The regulatory system appears to ban the beneficial while permitting the demonstrably harmful. This inconsistency reveals that the issue is not truly about safety, but about bureaucratic inflexibility and a failure to recognize non-European traditional knowledge as valid evidence. 

If safety were the genuine concern, surely the prioritization would be reversed: products that kill hundreds of thousands annually would face the strictest controls, while foods with centuries of safe consumption would be readily available.

Why Your Signature Matters

By signing this petition, you are demanding consistency, logic, and fairness in food regulation. You are asserting your right to access the full spectrum of traditional wellness practices that humanity has developed across cultures. You are refusing to accept a double standard that permits harmful substances while blocking beneficial ones based solely on geographical and cultural bias.

Your signature supports evidence-based policy that respects both scientific research and traditional knowledge, that prioritizes genuine health protection over bureaucratic box-ticking, and that treats you as a capable adult entitled to make your own informed wellness decisions.

This is about reclaiming your autonomy over your own body, supporting cultural diversity in health practices, demanding regulatory consistency, and ensuring that laws serve people rather than simply perpetuating arbitrary restrictions.

Sign this petition to tell Parliament that you deserve access to the same traditional health foods that billions of people worldwide use safely every day.

 
Health Benefits of Turkey Tail and Cordyceps

Turkey Tail (Trametes versicolor)

Turkey tail mushroom has garnered significant attention in both traditional medicine and modern research for its potential therapeutic properties. The mushroom contains polysaccharopeptides, particularly PSK (polysaccharide-K) and PSP (polysaccharide-peptide), which have demonstrated immunomodulatory effects in various studies.

Research suggests that turkey tail may support immune system function by enhancing the activity of natural killer cells and other immune components. Some studies have explored its potential as an adjunct therapy in cancer treatment, with particular interest in its ability to support patients undergoing chemotherapy. The mushroom's high antioxidant content, including phenols and flavonoids, may contribute to cellular protection against oxidative stress.

Additionally, turkey tail contains prebiotics that may support gut health by promoting beneficial bacterial growth in the digestive system. This connection between gut health and overall immunity has made turkey tail a subject of ongoing scientific investigation.

Cordyceps (Cordyceps militaris and Cordyceps sinensis)

Cordyceps mushrooms have been prized in traditional Chinese and Tibetan medicine for centuries, valued for their purported ability to enhance vitality and endurance. Modern research has begun exploring the biochemical basis for these traditional uses.

Studies indicate that cordyceps may improve exercise performance and reduce fatigue by enhancing the body's production of adenosine triphosphate (ATP), which is essential for delivering energy to muscles. This has made cordyceps popular among athletes and those seeking to improve physical performance.

The mushroom also shows promise in supporting cardiovascular health, with research suggesting potential benefits for heart rhythm regulation and cholesterol management. Cordyceps contains cordycepin, a compound that has demonstrated anti-inflammatory properties in laboratory studies.

Furthermore, research has explored cordyceps' potential effects on blood sugar regulation, kidney function, and libido. The adaptogenic properties attributed to cordyceps suggest it may help the body manage various forms of stress, though more human studies are needed to confirm many of these effects.

The EU Novel Foods Regulation: A Critical Analysis

The 1997 Cutoff Date and Its Implications

The European Union's Novel Foods Regulation uses May 15, 1997, as the pivotal date for determining whether a food requires novel food authorization before being placed on the EU market. Any food not consumed to a significant degree within the EU before this date is classified as "novel" and must undergo extensive safety assessment and authorization procedures before sale.

This regulatory framework has created significant controversy regarding adaptogenic mushrooms, particularly species like turkey tail and cordyceps that have extensive histories of traditional use in Asian cultures but limited documented consumption within Europe prior to 1997.

The Case Against the Current Regulatory Approach

Historical Precedent and Cultural Bias

The selection of 1997 as a cutoff date appears arbitrary when considering the centuries-long consumption history of these mushrooms in Asian traditional medicine. Turkey tail and cordyceps have been consumed in various forms, including tinctures, teas, and powdered extracts, across China, Japan, Korea, and other Asian nations for hundreds, if not thousands, of years.

This extensive historical use represents a form of long-term safety data that arguably surpasses the requirements for many foods already approved in the EU market. The regulation's focus on consumption within the EU effectively dismisses the collective experience of billions of people across multiple generations, raising questions about whether the law inadvertently privileges European dietary traditions over equally valid non-European food cultures.

The Tincture and Extract Question

A particularly contentious aspect of the EU's application of novel food regulations concerns concentrated forms of these mushrooms. While whole dried mushrooms might have some documented use in European specialty markets prior to 1997, tinctures and extracts face additional regulatory hurdles.

This creates an inconsistency: if the whole mushroom is safe for consumption, the logical extension would be that concentrated forms, which contain the same compounds in different ratios, should not require entirely separate approval processes.

Traditional preparation methods in Asian medicine specifically involved creating concentrated extracts and tinctures to enhance bioavailability and therapeutic effects. Dismissing these preparation methods as "novel" ignores the sophisticated understanding of food preparation developed over centuries.

Economic and Innovation Barriers

The novel foods authorization process is expensive and time-consuming, often requiring extensive toxicological studies, detailed compositional analysis, and proposed uses and use levels. These requirements can cost hundreds of thousands of euros and take several years to complete. For small and medium-sized enterprises, particularly those in developing nations where these mushrooms are traditionally harvested and processed, these barriers are often insurmountable.

This regulatory burden effectively restricts market access and consumer choice, preventing EU citizens from accessing foods that are freely consumed and considered safe in much of the rest of the world. It also stifles innovation in the functional foods and natural health products sector.

Scientific Consistency and Risk Assessment

Critics argue that the EU's approach lacks proportionality when comparing the regulatory treatment of traditional mushroom extracts with other foods. Many foods with far shorter histories of human consumption have been granted easier market access, while mushrooms with extensive traditional use face stringent barriers. This inconsistency raises questions about whether the regulatory framework appropriately balances consumer protection with reasonable risk assessment.

Conclusion

While the Novel Foods Regulation serves the important purpose of ensuring food safety in an era of rapid technological and commercial innovation, its application to traditional foods with extensive histories of safe consumption in non-European cultures deserves critical reexamination.

The case of adaptogenic mushrooms like turkey tail and cordyceps highlights the need for regulatory frameworks that can acknowledge and appropriately evaluate traditional knowledge and historical use patterns from diverse cultural contexts, rather than defaulting to a Eurocentric baseline that may inadvertently discriminate against globally recognized traditional foods.